Webinar Summary – Addressing Diagnostic Complexities Of Bipolar Disorder (Distinguishing Bipolar Series Part 2)
This summary was developed utilizing the full recorded presentation of this webinar. You can access the full sourcing, polling results, recording, or presentation slides here: https://psychu.org/addressing-diagnostic-complexities-bipolar-disorder-distinguishing-bipolar-series-part-2/.
On March 14, 2018, Dr. Rif El-Mallakh and Dr. Mark Zimmerman convened to discuss the difficulty that clinicians may experience in diagnosing bipolar disorder (BD) due to shared clinical features and other confounding comorbidities. Speakers were paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.
Rif El-Mallakh, M.D., is a Professor and Director of the Mood …
Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI). Specific PsychU programs may be supported by OPDC, OAPI and other committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsor or the sponsors of the specific PsychU program in which such opinions are expressed. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC and OAPI.